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Abstract
Introduction: In women showing impaired fertility, a decreased response to
ovarian stimulation is a major problem, limiting the number of oocytes to be
used for assisted reproduction techniques (ART). Despite the several definitions
of poor response, it is still a matter of debate whether young poor responder
patients also show a decrease in oocyte quality. The objective in this study was
to investigate whether poor ovarian response to the superstimulation protocol
is accompanied by impaired oocyte quality.
Material and methods: This study included 313 patients younger than 35 years
old, undergoing intracytoplasmic sperm injection. Patients with four or fewer
MII oocytes (poor-responder group, PR, n = 57) were age-matched with
normoresponder patients (NR, n = 256).
Results: A higher rate of oocyte retrieval and a trend towards an increase in MII
oocyte rate were observed in the NR group when compared to the PR group
(71.6 ±1.1% and 74.1 ±1.0% vs. 56.3 ±2.9% and 66.5 ±3.7%; p < 0.0001 and 
p = 0.056, respectively). A trend toward increased implantation rates was
observed in the NR group when compared to the PR group (44 and 24.5 ±2.0%
vs. 28.8 and 16.4 ±3.9%; p = 0.0305 and p = 0.0651, respectively).
Conclusions: Low response to ovarian stimulation is apparently not related to
impaired oocyte quality. However, embryos produced from poor responder
oocytes show impaired capacity to implant and to carry a pregnancy to term.
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Introduction
Approximately 40% to 50% of all infertility (i.e., no pregnancy after at
least 1 year of unprotected intercourse [1]) occurs due to female factors.
Ovulation dysfunction [2], scarring from inflammatory or infectious diseases
[3], nutrient deficiencies [4], hormone imbalance [5], ovarian cysts [6], and
transport system abnormality from the cervix through the fallopian tubes
[7] are some of the causes of female infertility. Assisted reproductive
technologies (ART) have been developed in order to overcome both female
and male infertility. In women showing impaired fertility, a decreased
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response to ovarian stimulation, with incidence
estimated to range from 9% to 24% [8-10], is
a major problem, limiting the number of oocytes to
be used for ART.
It is well known that ovarian poor response to
stimulation protocols increases as women get older
[10]. Furthermore, a decline in both oocyte quantity
and quality is observed in older women (e.g., > 35
years old) [11]. On the other hand, in younger
patients, a trend towards decreased fertility was
observed when response to ovarian stimulation is
impaired, despite no differences in ovarian reserve
[12]. A hypothesis to explain such results is
a decrease in oocyte quality. Despite the several
definitions of poor response [12-16], it is still
a matter of debate whether young poor responder
patients also show a decrease in oocyte quality. The
present study was performed in order to study
whether ovarian response is related to decline in
oocyte quality in women younger than 35 years old,
avoiding the effect of age on oocyte quality. 
Material and methods
Patients 
Data of intracytoplasmic sperm injection (ICSI)
cycles performed in 313 patients younger than 35
years old were included in this retrospective study.
All cases of surgically retrieved sperm were
excluded from the study. Patients were divided into
those who produced four or less MII oocytes (poor-
responder, PR group, n = 57) after controlled ovarian
stimulation (COS) and those in whom five or more
oocytes were retrieved (normoresponder, NR group,
n = 256). Written informed consent was obtained,
in which patients agreed to share the outcomes of
their own cycles for research purposes, and the
study was approved by the local institutional review
board.
Ovarian stimulation and oocyte retrieval
Controlled ovarian stimulation was achieved by
long pituitary down-regulation using a gonado  -
tropin-releasing hormone agonist (GnRHa, Lupron
Kit™, Abbott S.A Societé Française des Laboratoires,
Paris, France) followed by ovarian stimulation with
recombinant FSH (Gonal-F®, Serono, Geneve,
Switzerland). The follicular dynamic was followed
by ultrasound starting on day 4 of gonadotropin
administration. When adequate follicular growth
and serum oestradiol levels were observed,
recombinant human chorionic gonadotrophin 
(r-hCG, Ovidrel™, Serono, Geneve, Switzerland) was
administered to trigger final follicular maturation.
Oocytes were collected 35 h after hCG adminis  -
tration by transvaginal ultrasound ovum pick-up.
Oocytes were stored in human tubal cultured
medium (HTF, Irvine Scientific, Santa Ana, USA)
supplemented with 10% Human Synthetic Albumin
(HSA, Irvine Scientific, Santa Ana, USA) covered with
oil (Ovoil™, Vitrolife, Kungsbacka, Sweden) at 37°C
in 6% CO2 for 5 h, before cumulus cell removal.
Cumulus cells were removed from the oocytes by
placement of HEPES-buffered medium containing
hyaluronidase (80 IU/ml Irvine Scientific, Santa Ana,
USA). The remaining surrounding cumulus cells
were then removed by gently pipetting with a hand-
drawn Pasteur pipette (Humagen Fertility
Diagnostics, Charlottesville, USA).
Preparation of oocytes and morphology
assessment
Retrieved oocytes were maintained in human
tubal cultured medium (HTF, Irvine Scientific, Santa
Ana, USA) supplemented with 10% Human
Synthetic Albumin (HSA, Irvine Scientific, Santa Ana,
USA) covered with mineral oil (OvoilTM Vitrolife) for
2-3 h before cumulus cell removal. Surrounding
cumulus cells were removed with exposure to
a HEPES-buffered medium containing hyaluronidase
(80 IU/ml, Irvine Scientific, Santa Ana, USA). The
remaining cumulus cells were then mechanically
removed by gently pipetting with a hand-drawn
Pasteur pipette (Humagen Fertility Diagnostics,
Charlottesville, USA). Oocyte morphology was
assessed using an inverted Nikon Diaphot
microscope (Eclipse TE 300; Nikon®, Tokyo, Japan)
with a Hoffmann modulation contrast system under
400× magnification, just before sperm injection 
(3-4 h after retrieval). The following extracyto  -
plasmic (EC) and intracytoplasmic (IC) morpho  -
logical abnormalities of the oocyte were recorded:
(i) large perivitelline space size (EC), (ii) perivitelline
space granularity (EC), (iii) fragmented first polar
body (EC), (iv) increased cytoplasmic granularity (IC;
dark centre or homogeneous), (v) smooth
endoplasmic reticulum clusters (IC) and (vi)
vacuoles in the ooplasm (IC). Normal oocytes
showed clear cytoplasm with uniform texture and
homogeneous fine granularity that did not contain
inclusions, a small perivitelline space without
granularity, and a single unfragmented first polar
body (Veeck 1988).
Intracytoplasmic sperm injection procedure
Intracytoplasmic sperm injection was performed
in MII oocytes according to the technique described
by Palermo et al. [17]. Oocytes were transferred into
the micro-injection dish, prepared with drops of
HEPES-buffered HTF (Irvine Scientific, Santa Ana,
USA) covered under oil and placed on a heated
stage of an inverted microscope. Approximately 
16 h after ICSI, fertilization was confirmed by the
presence of two pronuclei and the extrusion of the
second polar body. Embryos were kept in a 50 μl
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drop of HTF medium supplemented with 10% HAS
under oil, in a humidified atmosphere of 5% CO2 in
air, at 37°C, until transfer. Embryo transfer was
performed on the third day of development. 
Clinical follow-up
Serum β-hCG levels were assessed for the first
time 12 days after replacement of the embryos.
Clinical pregnancy was defined when a transvaginal
ultrasound scan, performed 3-4 weeks after embryo
transfer, revealed the presence of a gestational sac.
To calculate the implantation rate, the number of
gestational sacs was divided by the number of
embryos transferred. Miscarriage was defined as
spontaneous abortion before 20 weeks’ gestation. 
Data analysis
The two groups were compared with regard to:
(i) age; (ii) oocyte yield (no. of retrieved oocytes/no.
follicles); (iii) metaphase II oocyte rate (MII
oocytes/total number of retrieved oocytes); (iv)
percentage of extracytoplasmic (i.e., large perivi  -
telline space size, perivitelline space granularity, and
fragmented first polar body) and intracytoplasmic
(i.e., increased cytoplasmic granularity, smooth
endoplasmic reticulum clusters, and vacuoles in the
ooplasm); (v) percentage of high quality embryos
on the third day of development (no. of high quality
embryos/no. of fertilized MII oocytes); (vi)
pregnancy rate; (vii) implantation, and (viii)
miscarriage rates.
High quality embryos were defined as those
showing 6-8 cells on the third day of development,
less than 15% fragmentation, symmetric blasto  -
meres, absence of multinucleation, and absence of
zona pellucida dysmorphism. 
Statistical analysis
Results were expressed as mean ± standard
error for numeric variables, while proportions (%)
were used for categorical variables. Mean values
were compared by Student’s t parametric test or
Mann-Whitney non-parametric test, according to
Gaussian distribution and variance homogeneity.
Proportions were compared by the χ2 or Fisher
exact test, only when the expected frequency was
five or less. Results were considered to be
significant at the 5% critical level (p < 0.05). Data
analysis was carried out using SAS System for
Windows.
Results
Poor responder patients showed higher age than
the normal responders (NR: 30.4 ±0.2 vs. PR: 31.7
±0.3, p = 0.0324). Furthermore, despite similar
duration of gonadotrophin stimulation in the 
two groups, significantly increased doses of
gonadotrophins were used in the PR group.
Oestradiol concentration on the day of hCG and
oocyte yield were significantly lower in the PR group
(Table I).
Oocyte retrieval rate was significantly lower for
the PR group than for the NR group (56.3 ±2.9 vs.
71.6 ±1.1, respectively, p < 0.0001, Table I). Similarly,
a trend for a difference was found when comparing
MII oocytes rates among groups (PR: 66.5 ±0.3.7 vs.
74.1 ±1.0, p = 0.056).
Regarding oocyte morphological abnormalities,
the PR group showed a higher percentage of
oocytes showing a large perivitelline space when
compared to the NR group (31.8 ±4.7 vs. 21.5 ±1.8%,
respectively; p = 0.0202). No differences were found
between groups regarding the remaining oocyte
morphological abnormalities (Table II).
Despite the fact that no differences were found
among groups in the rate of high quality embryos
(PR: 49.7 ±5.3 vs. NR: 50.3 ±1.9, p = 0.9135), the
pregnancy rate was significantly different (PR: 28.8
vs. NR: 44%, p = 0.0305, Table III). A trend towards
a higher implantation rate was found in normal
responder patients when compared to poor
responders (24.5 ±2.0 vs. 16.4 ±3.9, respectively, 
p = 0.0651, Table III).
Discussion
There is no universal definition of poor
responder. Numbers of mature follicles noted on
Study groupV alue of p
PR (n = 57) NR (n = 256)
Age [years] 31.7 ±0.3 30.4 ±0.2 0.0324
Total gonadotrophin dose [IU] 2318.1 ±117.4 2023.8 ±43.8 0.0211
Oestradiol on day of hCG [pg/ml] 388.7 ±76.8 1022.74 ±95.9 0.0020
No. of retrieved oocytes/No. of follicles [%] 56.3 ±2.9 71.6 ±1.1 < 0.0001
MII oocytes/total number of retrieved oocytes [%] 66.5 ±3.7 74.1 ±1.0 0.0546
Values expressed as mean ± SEM, unless otherwise noted. Student’s t-test
Table I. Stimulation cycle characteristics in a group of poor responder patients younger than 35 years (PR group)
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ultrasound [13], high basal FSH levels in the early
follicular phase [16], cumulative dose or days of
gonadotropin requirements in a prior cycle [18], and
numbers of mature oocytes obtained [19] have been
used. In the present experiment, a reduced number
of MII oocytes (e.g., less than 5) was used to define
poor response to ovarian stimulation. Hellberg et
al. [20], verified that women showing less than four
retrieved oocytes showed a significant decrease in
pregnancy rate following IVF. Furthermore, according
to Arnot et al. [21], IVF success is significantly related
to the number of oocytes retrieved. Therefore,
women showing a limited number of oocytes
following ovum pick-up, especially MII oocytes,
present impaired embryo production and, therefore,
decreased chances of pregnancy. 
Studies indicate the deleterious influence of age
on oocyte yield and quality. In fact, older women
(above 35 years old) present a reduction in follicular
diameter when compared to younger women,
suggesting that only larger follicles are generally
recruited in the beginning of reproductive life, and
as women get older the remaining follicles show
a decrease not only in diameter but in quality as
well [22]. The limit of 35 years old has been widely
used in studies concerning the effect of age on
assisted reproduction outcome. In the present study,
even in women younger than 35 years old, women
in the poor responder group were statistically older
than women in the normal responder group,
indicating that the age of 35 years may not be ideal
to study the influence of age on ovarian response
to stimulation. 
Besides showing a lower number of oocytes
retrieved, the rates of oocyte retrieval and MII
oocyte retrieved was also lower in poor responder
women. Similar results were obtained by Younis et
al. [23]; 14% of patients showed a decrease in
oocyte retrieval rate. A hypothesis to explain such
results would be the presence and aspiration of
a significant number of small follicles, which may
not contain eggs capable of collection, such as
those observed in polycystic ovary syndrome [24].
Further studies are necessary to confirm this
hypothesis.
In order to be considered morphologically
normal, an MII oocyte should present a round, even
shape, cytoplasm with homogeneous granularity,
a small perivitelline space with no debris, and
a transparent zona pellucida (ZP) [25]. The detailed
analysis of oocyte morphological status during the
IVF cycle is impaired by the surrounding cumulus
cells. On the other hand, cumulus cells are removed
when employing ICSI allowing the visualization of
morphological structure and nuclear maturity.
Furthermore, the impact of oocyte morphology on
fertility when using IVF/ICSI is a matter of debate
[26]. In the present experiment, the group of poor
responder patients showed increased percentages
of large perivitelline space. This was accompanied
by a significant decrease in pregnancy rate and
a trend towards impaired embryo implantation. This
Study groupV alue of p
PR (n = 57) NR (n = 256)
Large perivitelline space size 31.8 ±4.7 21.5 ±1.8 0.0202
Perivitelline space granularity 33.7 ±4.7 36.1 ±2.2 0.6423
Fragmented first polar body 26.8 ±4.3 31.7 ±2.0 0.2864
Increased cytoplasmic granularity 61.3 ±5.4 66.1 ±2.5 0.3975
Smooth endoplasmic reticulum clusters 8.0 ±3.0 6.8 ±1.2 0.7025
Vacuoles in the ooplasm 3.1 ±1.5 3.3 ±0.6 0.8617
Values expressed as mean ± SEM, unless otherwise noted, Student’s t-test
Table II. Effect of ovarian response (poor vs. normal) on oocyte morphology of patients younger than 35 years
Study groupV alue of p
PR (n = 57)  NR (n = 256) 
Rate of high quality embryos  49.7 ±5.3 50.3 ±1.9 0.9135a
Pregnancy rate  28.8 44 0.0305b
Implantation rate 16.4 ±3.9 24.5 ±2.0 0.0651a
Abortion rate 10.1 6.2 0.2933b
Values are percentages. aStudent’s t-test, bFisher exact test
Table III. Intracytoplasmic sperm injection cycle outcomes in a group of poor responder patients younger than 
35 years (PR group) compared with age-matched normoresponders
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morphological abnormality may affect oocyte
survival [27, 28] and fertilization rate after
insemination by ICSI [29]. This feature seems to
reflect an over-maturity of the oocytes at the
moment of ICSI [30]. However, different studies
have failed to find a correlation between size and
shape of the perivitelline space and fertilization rate
and embryo development [31, 32]. The negative
effect of this morphology may be related to its
extent and to the simultaneous presence of other
abnormalities, such as non-nucleated fragments.
However, in the present study when scores of
abnormalities were considered (i.e., score 1: one
abnormality; score 2: two abnormalities; score 3:
three abnormalities), no differences were found
between groups (data not shown), indicating that
poor capacity of embryos produced from poor
responder patients is not related to the number of
morphological abnormalities found in the oocytes.
However, further studies are necessary to evaluate
the competence of embryos produced from oocytes
showing a large perivitelline space.
Despite the higher number of available embryos
in the NR group, which may have influenced
pregnancy rates by limiting the selection for
transfer, the trend towards a higher implantation
rate indicates that embryos collected from poor
responder patients may present impaired biological
capacity.
In conclusion, our results suggest that although
apparently high quality embryos may be produced
in women showing poor response to ovarian
stimulation, care must be taken regarding the
possibility of pregnancy being carried to term in
such patients. 
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